Anazaohealth (United States) has no DMF, CEP or site registration linked in our records. 11 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Anazaohealth: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/anazaohealth

Overview

Anazaohealth is a pharmaceutical company headquartered in Tampa, United States.

FDA compliance signals

11 FDA enforcement records linked to this company.

  • 4832025-08-08

    Absence of Written Procedures

  • 4832025-08-08

    Complaint Investigation/Follow-Up Findings

  • 4832025-08-08

    Procedures for sterile drug products

  • 4832025-08-08

    Complete test data included in records

  • recall — Class II2024-01-03

    Presence of Particulate Matter.

  • recall — Class II2024-01-03

    Presence of Particulate Matter.

  • warning_letter2021-08-19

    FDA Warning Letter (drug product)

  • 4832019-09-19

    Cleaning System

  • 4832019-09-19

    Product flow through building is inadequate

  • warning_letter2015-12-09

    FDA Warning Letter (drug product)

  • recall — Class II2015-02-18

    Good Manufacturing Practices Deviations: The product has an active pharmaceutical ingredient from an unapproved source.

For suppliers

Is this Anazaohealth?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.